Indications
Rafter 2.5 mg tablet is used to help prevent atherothrombotic events in adult patients following an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB), and is given together with Aspirin alone or with Aspirin plus Clopidogrel or Ticlopidine. Rafter 10 to 20 mg tablet is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to reduce the risk of their recurrence; and for the prevention of DVT, which may lead to PE, in patients undergoing knee or hip replacement surgery.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Rivaroxaban is a highly selective agent that works by directly inhibiting factor Xa. By blocking factor Xa, it interrupts both the intrinsic and extrinsic pathways of the blood clotting cascade and reduces the formation of thrombin. It does not inhibit thrombin (activated factor II) itself, and it has not been shown to affect platelets.
Pregnancy & Breastfeeding
Rivaroxaban falls under pregnancy category C. No adequate, well-controlled studies have looked at its use in pregnant women, so a safe dosing schedule for pregnancy has not been established. Whether Rivaroxaban passes into human breast milk is also unknown, and its safety and effectiveness in breastfeeding mothers have not been established.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.